Publication of Statistical Results

News Highlights

According to statistical results published on April 30, 2026, the value of choosing third-party succession over closure or business cessation for the successor issue of medical institutions was suggested. In particular, the importance of early preparation in 5-10 year increments, starting around age 60 for chairpersons and directors, was emphasized. Utilizing specialized advisors in the medical industry is considered effective in this process.

M&A Medical Editorial Department’s Perspective

The published statistical results once again highlight the importance of business succession planning for medical institution executives, especially chairpersons and directors, as they approach age 60. Rather than simply dismissing it as a “successor issue,” the data supports the value of continuing the business through third-party succession, i.e., M&A, thereby avoiding closure or cessation. For example, if a clinic supporting regional healthcare were to close due to a lack of successors, the impact on local residents would be immeasurable. However, by consulting early with specialized advisors, such as those at CentralMedience Inc., who are knowledgeable in medical M&A, it becomes possible to consider appropriate M&A schemes, select potential counterparties, and ensure a smooth handover. A preparation period of 5 to 10 years can be considered sufficient time to arrange essential elements for M&A success, such as financial and legal due diligence, employee employment retention, and business value enhancement.

Points Raised by This News

• Third-party succession preparation over a 5-10 year span, starting around age 60, is an effective measure to avoid closure or cessation.
• Statistical data objectively suggests the value of M&A in the business continuity of medical institutions.
• From the perspective of maintaining regional healthcare, third-party succession can be an important option.
• Utilizing specialized advisors is key to smoothly navigating the complex process of medical institution M&A.

Practical Questions Arising from This News

• What specific third-party succession schemes can be considered?
• What kind of support do advisors specializing in medical M&A provide?
• If there are no successor candidates, are there any options other than M&A for business continuity?

If You Feel “Should I Consult?”

If you are around 60 years old and have vague concerns about a lack of successors or business succession, these statistical results may be a sign that you should take action “now.” The value of considering the option of passing on your business to the next generation through M&A, rather than simply ending your contribution to regional healthcare through closure or cessation, is significant. By consulting early with specialists like CentralMedience Inc., the future of your clinic could change dramatically. Why not start by organizing your current situation and gathering information on M&A possibilities?

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a Small and Medium Enterprise Agency-certified M&A support institution with a complete success-fee system. Consultations are accepted with strict confidentiality. Free consultations are available here.